Research Operations
The Revolving Door of Research: The Resourceful Way to Run Trials
Examine the current state of industry resources, resourcing implications, and the way we can now think of work: remote, hybrid, or on-site.
Developing an Enterprise Roadmap to Post Authorization Safety Studies
Learn how an organization achieved organization-wide compliance and managed its post-authorization safety studies.
Top Barriers to Participation in Clinical Trials
Understanding the factors that influence the decision to participate in a study helps research professionals diagnose enrollment problems.
Return of Research Results to Study Participants
Research into participant experiences has consistently shown their desire to learn the results of research to which they’ve contributed.
Common Pitfalls in Preparing an IND Application
While the IND application process may be straightforward to some, we explore the most common pitfalls as sponsors prepare for submission.
AI in Clinical Research
In this episode, we explore the ethics and implications of artificial intelligence in clinical research.
4 Questions to Ask When Establishing a Pharmacovigilance Organization
Four common but critical questions for emerging biotech organizations establishing a pharmacovigilance (PV) organization.
A Checklist for Optimizing Clinical Trial Study Startup Activities
This checklist outlines key milestones and considerations for sites and sponsors in the clinical trial study startup process.
Common Elements of IRB Assessments
Like other IRBs, Advarra is subject to inspections from time to time. What standards are we measured against?
How Sites Want to be Engaged
Explore research programs' case studies where engagement strategies increased recruitment, reduced deviations, and achieved enrollment goals
Large NCI-designated Hospital System Trains 400 End Users, Resulting in Increased Levels of Efficiency and Consistency
Read how this hospital system completed required trainings remotely, saving the organization time as staff learned the technology.